510(k) · Radiology

Neuro Insight V1.0

by Olea Medical S.A.S.

Neuro Insight V1.0 is an AI-enabled medical device from Olea Medical S.A.S. that the U.S. FDA cleared through 510(k) K243681 on July 23, 2025. Its lead review panel is Radiology and its primary product code is LLZ (System, Image Processing, Radiological).

See also FDA-cleared AI radiology devices in 2025, all FDA AI clearances in 2025, top radiology AI devices.

Key facts

Submission numberK243681
Pathway510(k)
Date of final decision
Company (FDA list)Olea Medical S.A.S.
Lead review panelRadiology
Primary product codeLLZ — System, Image Processing, Radiological
Applicant (openFDA)Olea Medical S.A.S.
Applicant locationLa Ciotat, FR
Device classClass 2
Regulation number21 CFR 892.2050
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. Neuro Insight V1.0 went through this pathway (K243681).

openFDA lists it as a Class 2 device under 21 CFR 892.2050. Class II devices are moderate risk and are subject to general and special controls.

Product code LLZ covers 161 devices on the FDA AI list. By decision date, this device is #158 of 161 under that code. Olea Medical S.A.S. has 1 AI-enabled device on the list, and the Radiology panel accounts for 1,230 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code LLZ)